Sort
3,198 grants matching “mrna vaccine”
Therapeutic DNA vaccination and Immune Checkpoints in Recurrent Respiratory Papillomatosis
$198,053Simon R Best · Johns Hopkins University · K23 · FY2017 · DC
Therapeutic DNA vaccination and Immune Checkpoints in Recurrent Respiratory Papillomatosis
$197,903Simon R Best · Johns Hopkins University · K23 · FY2016 · DC
NK cells and IL-15 in the human innate immune response to tuberculosis
$197,625Peter F. Barnes · University Of Texas Hlth Ctr At Tyler · R21 · FY2007 · HL
Immunomodulatory Function of Epithelial Exosomes in Respiratory Syncytial Virus Infection
$197,500Antonella Casola · University Of Texas Med Br Galveston · R21 · FY2020 · AI
Decoding the coding and non-coding transcriptomes of Orientia tsutsugamushi in target host cells
$197,500Hema Prasad Narra · University Of Texas Med Br Galveston · R21 · FY2021 · AI
Mechanism of viral RNP recognition by the envelope glycoprotein and its role in RNA segment packaging in Rift Valley Fever phlebovirus
$197,500Shinji Makino · University Of Texas Med Br Galveston · R21 · FY2021 · AI
mRNA COVID-19 Vaccines Delivered with Plant Virus/Polymer Devices
$197,500Nicole Franziska Steinmetz · University Of California, San Diego · R21 · FY2022 · AI
Deciphering the Molecular Mechanisms of Response to COVID Vaccine in Kidney Transplant Recipients
$197,333Jonathan S Maltzman · Palo Alto Veterans Instit For Research · R21 · FY2024 · AI
mRNA/miRNA Regulation of Host Resistance and Control in HIV-1 Discordant Couples
$197,010Jairam Rao Lingappa · University Of Washington · R21 · FY2011 · AI
Cellular RNA binding and regulation by NFX1-123 and its perturbation by high risk human papillomavirus E6
$196,875Rachel Adria Katzenellenbogen · Indiana University Indianapolis · R21 · FY2019 · AI
WNPRC ELITE CONTROLLER RESOURCE
$196,590David I Watkins · University Of Wisconsin-Madison · P51 · FY2009 · RR
Tolerance-Inducing mRNA Nanoparticles to Treat Type 1 Diabetes
$196,500Jordan Green · Johns Hopkins University · R56 · FY2024 · DK
Therapeutic DNA vaccination and Immune Checkpoints in Recurrent Respiratory Papillomatosis
$196,433Simon R Best · Johns Hopkins University · K23 · FY2019 · DC
Therapeutic DNA vaccination and Immune Checkpoints in Recurrent Respiratory Papillomatosis
$195,893Simon R Best · Johns Hopkins University · K23 · FY2020 · DC
Vaccine-induced SARS-CoV-2-specific T cell responses in patients with X-linked Agammaglobulinemia
$195,770Kristina Abel · Univ Of North Carolina Chapel Hill · R21 · FY2024 · AI
Transcriptome profiling of Trypanosoma cruzi and its host cell
$195,652Barbara A Burleigh · Harvard School Of Public Health · R21 · FY2012 · AI
Midcareer Investigator Award in Patient-Oriented Research (K24)
$195,598Patricia L Hibberd · Massachusetts General Hospital · K24 · FY2013 · AT
Mechanism of Translation Elongation Factor 2 Inhibition by Bacterial Toxins
$195,560Terri Goss Kinzy · Univ Of Med/Dent Nj-R W Johnson Med Sch · R21 · FY2009 · AI
IN VIVO ANALYSIS OF SL ADDITION IN ASCARIS EMBRYOS
$195,423University Of Colorado Denver · R01 · FY2004 · AI
DELETION MUTAGENESIS WITHIN NONCODING SEGMENTS OF HIV1
$195,299Sir Mortimer B. Davis Jewish Gen Hosp · R01 · FY2000 · AI
Discovering new genes involved in monocyte-mediated protective anti-viral innate immunity through the generation of mice with targeted mutations
$195,000Luis J. Sigal · Thomas Jefferson University · R21 · FY2022 · AI
Defining vaccine immunogenicity and adoptive transfer in hematopoietic stem cell transplant recipients
$194,400Amy Caryn Sherman · Brigham And Women'S Hospital · K23 · FY2025 · AI
Stress induced changes to the human beta cell proteome
$194,375Howard W Davidson · University Of Colorado Denver · R21 · FY2020 · AI
HCV biology and inhibition visualized at the single molecule level
$194,375Nils G Walter · University Of Michigan At Ann Arbor · R21 · FY2015 · AI
mRNA encoding of immune receptor-targeting antibodies for the augmentation of vaccine-elicited cellular immunity.
$194,375Ross M Kedl · University Of Colorado Denver · R21 · FY2023 · AI